PLIN2 (perilipin 2) - Rat Genome Database
Submit Data |  Help |  Video Tutorials |  News |  Publications |  FTP Download |  REST API |  Citing RGD |  Contact   
Gene: PLIN2 (perilipin 2) Homo sapiens
Analyze
Symbol: PLIN2
Name: perilipin 2
RGD ID: 730882
HGNC Page HGNC
Description: Predicted to be involved in lipid storage and positive regulation of sequestering of triglyceride. Localizes to lipid droplet.
Type: protein-coding
RefSeq Status: REVIEWED
Also known as: ADFP; adipophilin; adipose differentiation-related protein; ADRP; MGC10598; perilipin-2
RGD Orthologs
Mouse
Rat
Chinchilla
Bonobo
Dog
Squirrel
Pig
Green Monkey
Naked Mole-Rat
Alliance Genes
More Info more info ...
Related Pseudogenes: LOC645965  
Allele / Splice: See ClinVar data
Latest Assembly: GRCh38 - Human Genome Assembly GRCh38
Position:
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38.p13 Ensembl919,108,375 - 19,149,290 (-)EnsemblGRCh38hg38GRCh38
GRCh38919,108,391 - 19,127,518 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh37919,115,759 - 19,127,490 (-)NCBIGRCh37GRCh37hg19GRCh37
GRCh37919,115,759 - 19,127,604 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36919,105,759 - 19,117,573 (-)NCBINCBI36hg18NCBI36
Build 34919,105,759 - 19,117,573NCBI
Celera919,041,952 - 19,053,704 (-)NCBI
Cytogenetic Map9p22.1NCBI
HuRef919,077,611 - 19,089,275 (-)NCBIHuRef
CHM1_1919,115,770 - 19,127,537 (-)NCBICHM1_1
JBrowse: View Region in Genome Browser (JBrowse)
Model


Disease Annotations     Click to see Annotation Detail View

Gene-Chemical Interaction Annotations     Click to see Annotation Detail View
(+)-schisandrin B  (ISO)
(-)-epigallocatechin 3-gallate  (EXP)
(S)-nicotine  (ISO)
1,1-dichloroethene  (ISO)
1,2-dimethylhydrazine  (ISO)
1,3-dinitrobenzene  (ISO)
1,4-phenylenediamine  (EXP)
1-chloro-2,4-dinitrobenzene  (EXP)
1-naphthyl isothiocyanate  (ISO)
17beta-estradiol  (EXP,ISO)
2,2',4,4',5,5'-hexachlorobiphenyl  (ISO)
2,2',4,4'-Tetrabromodiphenyl ether  (EXP)
2,3,3,3-tetrafluoro-2-(heptafluoropropoxy)propanoic acid  (EXP)
2,3,7,8-tetrachlorodibenzodioxine  (ISO)
2,3,7,8-Tetrachlorodibenzofuran  (ISO)
2-hydroxypropanoic acid  (EXP)
3,3',4,4',5-pentachlorobiphenyl  (ISO)
3,3',5-triiodo-L-thyronine  (ISO)
3-isobutyl-1-methyl-7H-xanthine  (EXP,ISO)
3H-1,2-dithiole-3-thione  (ISO)
4,4'-sulfonyldiphenol  (EXP)
5-aza-2'-deoxycytidine  (EXP)
5-fluorouracil  (EXP)
6-(4-chlorophenyl)imidazo[2,1-b][1,3]thiazole-5-carbaldehyde O-(3,4-dichlorobenzyl)oxime  (EXP)
6-propyl-2-thiouracil  (ISO)
acetylsalicylic acid  (ISO)
aflatoxin B1  (EXP)
all-trans-retinoic acid  (EXP,ISO)
alpha-linolenic acid  (ISO)
amphetamine  (ISO)
arachidonic acid  (ISO)
arsane  (EXP)
arsenic atom  (EXP)
arsenous acid  (EXP)
atrazine  (EXP)
avobenzone  (EXP)
benzene-1,2,4-triol  (EXP)
benzo[a]pyrene  (EXP,ISO)
benzoates  (EXP)
beta-naphthoflavone  (ISO)
bezafibrate  (EXP)
bis(2-ethylhexyl) phthalate  (ISO)
bisphenol A  (EXP,ISO)
boron nitride  (EXP)
bromobenzene  (ISO)
buspirone  (ISO)
butanal  (EXP)
cadmium atom  (ISO)
cadmium dichloride  (EXP,ISO)
cannabidiol  (ISO)
capsaicin  (ISO)
carbon nanotube  (EXP,ISO)
celecoxib  (EXP)
chloropicrin  (EXP)
chloroprene  (ISO)
chlorpromazine  (ISO)
ciglitazone  (EXP)
ciprofibrate  (EXP,ISO)
cisplatin  (EXP,ISO)
clofibrate  (ISO)
clofibric acid  (EXP)
Clofop  (EXP)
copper atom  (EXP)
copper(0)  (EXP)
crocidolite asbestos  (EXP)
cyclosporin A  (EXP,ISO)
deoxynivalenol  (EXP)
dexamethasone  (EXP,ISO)
diarsenic trioxide  (EXP)
dibenz[a,h]anthracene  (ISO)
dibenzo[a,l]pyrene  (ISO)
dibutyl phthalate  (EXP,ISO)
dichloroacetic acid  (ISO)
dioxygen  (EXP,ISO)
diuron  (ISO)
doxorubicin  (EXP)
epoxiconazole  (ISO)
ethanol  (ISO)
ethyl methanesulfonate  (EXP)
farnesol  (EXP)
fenofibrate  (EXP,ISO)
folic acid  (ISO)
formaldehyde  (EXP)
fumonisin B1  (ISO)
gamma-linolenic acid  (EXP)
gemfibrozil  (ISO)
glafenine  (ISO)
glutathione  (ISO)
GW 4064  (EXP)
GW 501516  (EXP)
GW 7647  (EXP)
hexadecanoic acid  (EXP,ISO)
ibuprofen  (EXP,ISO)
indole-3-methanol  (ISO)
indometacin  (EXP)
isotretinoin  (EXP)
lead diacetate  (ISO)
leflunomide  (EXP)
Licarin A  (ISO)
metformin  (ISO)
methapyrilene  (ISO)
methotrexate  (EXP,ISO)
methyl methanesulfonate  (EXP)
mono(2-ethylhexyl) phthalate  (ISO)
Monobutylphthalate  (ISO)
N-[2-(4-bromocinnamylamino)ethyl]isoquinoline-5-sulfonamide  (ISO)
N-acetyl-L-cysteine  (ISO)
N-nitrosodiethylamine  (ISO)
N-nitrosodimethylamine  (ISO)
naproxen  (ISO)
nickel dichloride  (EXP)
nickel sulfate  (EXP)
nicotine  (ISO)
nimesulide  (EXP)
nitrofen  (ISO)
ochratoxin A  (EXP)
octadecanoic acid  (EXP)
oleic acid  (EXP,ISO)
oxaliplatin  (ISO)
paracetamol  (EXP,ISO)
perflubutane  (EXP)
perfluorobutyric acid  (EXP)
perfluorodecanoic acid  (EXP)
perfluorododecanoic acid  (EXP)
perfluoroheptanoic acid  (EXP)
perfluorohexanesulfonic acid  (EXP)
perfluorohexanoic acid  (EXP)
perfluorononanoic acid  (EXP)
perfluorooctane-1-sulfonic acid  (EXP,ISO)
perfluorooctanoic acid  (EXP,ISO)
perfluoroundecanoic acid  (EXP)
phenformin  (ISO)
phenobarbital  (EXP,ISO)
phorbol 13-acetate 12-myristate  (EXP)
pioglitazone  (EXP)
pirinixic acid  (EXP,ISO)
potassium chromate  (EXP)
potassium dichromate  (EXP)
pregnenolone 16alpha-carbonitrile  (ISO)
propiconazole  (ISO)
quinolin-8-ol  (EXP)
rac-lactic acid  (EXP)
resveratrol  (ISO)
rimonabant  (ISO)
rotenone  (ISO)
serpentine asbestos  (EXP)
silicon dioxide  (EXP)
sodium arsenate  (EXP)
sodium arsenite  (ISO)
sodium dichromate  (ISO)
sodium fluoride  (ISO)
Soman  (ISO)
steviol  (ISO)
stevioside  (ISO)
streptozocin  (ISO)
sumatriptan  (ISO)
sunitinib  (EXP)
Tesaglitazar  (EXP)
tetrachloroethene  (ISO)
tetrachloromethane  (ISO)
thioacetamide  (ISO)
titanium dioxide  (ISO)
tolcapone  (ISO)
topotecan  (ISO)
tributylstannane  (ISO)
Tributyltin oxide  (ISO)
triphenyl phosphate  (ISO)
troglitazone  (EXP,ISO)
trovafloxacin  (ISO)
tunicamycin  (EXP,ISO)
valproic acid  (EXP)
vancomycin  (ISO)
vinclozolin  (ISO)

Gene Ontology Annotations     Click to see Annotation Detail View

Biological Process

Cellular Component
cytoplasm  (ISO)
cytosol  (IBA,ISO)
endoplasmic reticulum  (TAS)
extracellular region  (TAS)
lipid droplet  (IBA,IDA,ISO)
nucleus  (IEA,ISO)
plasma membrane  (ISO,TAS)

Molecular Function
protein binding  (IPI,ISO)

Molecular Pathway Annotations     Click to see Annotation Detail View
References

Additional References at PubMed
PMID:1518805   PMID:7829101   PMID:9003395   PMID:9799447   PMID:12114189   PMID:12387890   PMID:12477932   PMID:12591929   PMID:14671211   PMID:14707038   PMID:14741744   PMID:15136565  
PMID:15146197   PMID:15336557   PMID:15489334   PMID:15545278   PMID:16230742   PMID:16391323   PMID:16489205   PMID:16808905   PMID:16884492   PMID:16936283   PMID:17200350   PMID:17322100  
PMID:17446422   PMID:17620659   PMID:17927964   PMID:18188946   PMID:18393390   PMID:18606814   PMID:18624398   PMID:18827892   PMID:18832575   PMID:19054096   PMID:19169702   PMID:19351497  
PMID:19460752   PMID:19602560   PMID:19638644   PMID:19717842   PMID:19843633   PMID:19851831   PMID:20032580   PMID:20118912   PMID:20143336   PMID:20661576   PMID:20887090   PMID:21566511  
PMID:21828233   PMID:21873635   PMID:22238364   PMID:22496505   PMID:22667335   PMID:22949030   PMID:22952953   PMID:23129790   PMID:23603836   PMID:23688400   PMID:23931576   PMID:23977392  
PMID:24405744   PMID:24577896   PMID:25172666   PMID:25279712   PMID:25559404   PMID:25595097   PMID:26166692   PMID:26181025   PMID:26443937   PMID:26598603   PMID:26636961   PMID:26728854  
PMID:26731658   PMID:26742848   PMID:27157138   PMID:27308945   PMID:27467545   PMID:27567691   PMID:27591428   PMID:28005267   PMID:28404922   PMID:28713961   PMID:29422264   PMID:29529198  
PMID:29733984   PMID:29749470   PMID:30178542   PMID:30288961   PMID:30351430   PMID:30400205   PMID:30425097   PMID:30467901   PMID:30559250   PMID:30591149   PMID:30626683   PMID:30639242  
PMID:30649995   PMID:30782775   PMID:30879968   PMID:31273897   PMID:31504629   PMID:31520166   PMID:31701069   PMID:31857696   PMID:31941931   PMID:31981756   PMID:32296183   PMID:32814053  


Genomics

Comparative Map Data
PLIN2
(Homo sapiens - human)
Human AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCh38.p13 Ensembl919,108,375 - 19,149,290 (-)EnsemblGRCh38hg38GRCh38
GRCh38919,108,391 - 19,127,518 (-)NCBIGRCh38GRCh38hg38GRCh38
GRCh37919,115,759 - 19,127,490 (-)NCBIGRCh37GRCh37hg19GRCh37
GRCh37919,115,759 - 19,127,604 (-)NCBIGRCh37GRCh37hg19GRCh37
Build 36919,105,759 - 19,117,573 (-)NCBINCBI36hg18NCBI36
Build 34919,105,759 - 19,117,573NCBI
Celera919,041,952 - 19,053,704 (-)NCBI
Cytogenetic Map9p22.1NCBI
HuRef919,077,611 - 19,089,275 (-)NCBIHuRef
CHM1_1919,115,770 - 19,127,537 (-)NCBICHM1_1
Plin2
(Mus musculus - house mouse)
Mouse AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
GRCm39486,545,147 - 86,588,518 (-)NCBIGRCm39mm39
GRCm38486,626,910 - 86,670,217 (-)NCBIGRCm38GRCm38mm10GRCm38
GRCm38.p6 Ensembl486,648,386 - 86,670,060 (-)EnsemblGRCm38mm10GRCm38
MGSCv37486,302,469 - 86,315,963 (-)NCBIGRCm37mm9NCBIm37
MGSCv36486,127,797 - 86,141,225 (-)NCBImm8
Celera485,171,641 - 85,185,400 (-)NCBICelera
Cytogenetic Map4C4NCBI
cM Map440.69NCBI
Plin2
(Rattus norvegicus - Norway rat)
Rat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
mRatBN7.25101,156,643 - 101,211,738 (-)NCBI
Rnor_6.0 Ensembl5104,984,414 - 105,010,857 (-)EnsemblRnor6.0rn6Rnor6.0
Rnor_6.05104,984,413 - 105,010,863 (-)NCBIRnor6.0Rnor_6.0rn6Rnor6.0
Rnor_5.05108,972,976 - 108,999,210 (-)NCBIRnor5.0Rnor_5.0rn5Rnor5.0
RGSC_v3.45105,718,496 - 105,732,817 (-)NCBIRGSC3.4rn4RGSC3.4
RGSC_v3.15105,723,721 - 105,738,043 (-)NCBI
Celera599,654,064 - 99,667,851 (-)NCBICelera
Cytogenetic Map5q32NCBI
Plin2
(Chinchilla lanigera - long-tailed chinchilla)
Chinchilla AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
ChiLan1.0 EnsemblNW_00495543421,574,292 - 21,580,988 (-)EnsemblChiLan1.0
ChiLan1.0NW_00495543421,573,860 - 21,580,990 (-)NCBIChiLan1.0ChiLan1.0
PLIN2
(Pan paniscus - bonobo/pygmy chimpanzee)
Bonobo AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
PanPan1.1919,421,928 - 19,537,676 (-)NCBIpanpan1.1PanPan1.1panPan2
PanPan1.1 Ensembl919,421,928 - 19,462,222 (-)Ensemblpanpan1.1panPan2
Mhudiblu_PPA_v0918,928,455 - 18,951,132 (-)NCBIMhudiblu_PPA_v0panPan3
PLIN2
(Canis lupus familiaris - dog)
Dog AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
CanFam3.1 Ensembl1138,940,065 - 38,959,070 (-)EnsemblCanFam3.1canFam3CanFam3.1
CanFam3.11138,940,063 - 38,959,126 (-)NCBICanFam3.1CanFam3.1canFam3CanFam3.1
Plin2
(Ictidomys tridecemlineatus - thirteen-lined ground squirrel)
Squirrel AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
SpeTri2.0NW_0049366521,039,248 - 1,059,983 (-)NCBISpeTri2.0SpeTri2.0SpeTri2.0
PLIN2
(Sus scrofa - pig)
Pig AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
Sscrofa11.1 Ensembl1203,683,862 - 203,709,274 (+)EnsemblSscrofa11.1susScr11Sscrofa11.1
Sscrofa11.11203,683,867 - 203,709,277 (+)NCBISscrofa11.1Sscrofa11.1susScr11Sscrofa11.1
Sscrofa10.21227,334,036 - 227,357,123 (+)NCBISscrofa10.2Sscrofa10.2susScr3
PLIN2
(Chlorocebus sabaeus - African green monkey)
No map positions available.
Plin2
(Heterocephalus glaber - naked mole-rat)
Molerat AssemblyChrPosition (strand)SourceGenome Browsers
JBrowseNCBIUCSCEnsembl
HetGla 1.0NW_00462473623,114,149 - 23,122,634 (-)NCBI

Position Markers
ADFP_2401  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37919,115,622 - 19,116,406UniSTSGRCh37
Build 36919,105,622 - 19,106,406RGDNCBI36
Celera919,041,815 - 19,042,599RGD
HuRef919,077,474 - 19,078,258UniSTS
STS-W55904  
Human AssemblyChrPosition (strand)SourceJBrowse
GRCh37919,115,973 - 19,116,215UniSTSGRCh37
Build 36919,105,973 - 19,106,215RGDNCBI36
Celera919,042,166 - 19,042,408RGD
Cytogenetic Map9p22.1UniSTS
HuRef919,077,825 - 19,078,067UniSTS
GeneMap99-GB4 RH Map964.22UniSTS
NCBI RH Map9230.1UniSTS

miRNA Target Status

Predicted Target Of
Summary Value
Count of predictions:1466
Count of miRNA genes:776
Interacting mature miRNAs:912
Transcripts:ENST00000276914, ENST00000380464, ENST00000380465, ENST00000411567, ENST00000434144, ENST00000464326, ENST00000472715, ENST00000475923, ENST00000494753
Prediction methods:Microtar, Miranda, Rnahybrid, Targetscan
Result types:miRGate_prediction

The detailed report is available here: Full Report CSV TAB Printer

miRNA Target Status data imported from miRGate (http://mirgate.bioinfo.cnio.es/).
For more information about miRGate, see PMID:25858286 or access the full paper here.


Expression


RNA-SEQ Expression
High: > 1000 TPM value   Medium: Between 11 and 1000 TPM
Low: Between 0.5 and 10 TPM   Below Cutoff: < 0.5 TPM

alimentary part of gastrointestinal system circulatory system endocrine system exocrine system hemolymphoid system hepatobiliary system integumental system musculoskeletal system nervous system renal system reproductive system respiratory system sensory system visual system adipose tissue appendage entire extraembryonic component pharyngeal arch
High 1 26 4 4 20 4 64 3 1 26 1 105 5
Medium 2182 2658 1499 604 1744 456 4197 1947 1069 340 1325 1444 152 1 1099 2718 6 2
Low 231 307 220 15 167 3 86 227 2634 49 109 131 20 65
Below cutoff 22 3 1 15 2 10 20 30 4 20 32 1

Sequence


Reference Sequences
RefSeq Acc Id: ENST00000276914   ⟹   ENSP00000276914
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,115,761 - 19,127,492 (-)Ensembl
RefSeq Acc Id: ENST00000380464   ⟹   ENSP00000369831
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,123,313 - 19,127,490 (-)Ensembl
RefSeq Acc Id: ENST00000380465   ⟹   ENSP00000369832
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,123,235 - 19,127,476 (-)Ensembl
RefSeq Acc Id: ENST00000434144   ⟹   ENSP00000403421
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,121,100 - 19,149,278 (-)Ensembl
RefSeq Acc Id: ENST00000464326
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,108,375 - 19,118,446 (-)Ensembl
RefSeq Acc Id: ENST00000472715
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,125,633 - 19,127,490 (-)Ensembl
RefSeq Acc Id: ENST00000475923
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,125,506 - 19,127,475 (-)Ensembl
RefSeq Acc Id: ENST00000494753
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38.p13 Ensembl919,129,737 - 19,149,290 (-)Ensembl
RefSeq Acc Id: NM_001122   ⟹   NP_001113
RefSeq Status: REVIEWED
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38919,115,761 - 19,127,492 (-)NCBI
GRCh37919,115,759 - 19,127,604 (-)ENTREZGENE
Build 36919,105,759 - 19,117,573 (-)NCBI Archive
HuRef919,077,611 - 19,089,275 (-)ENTREZGENE
CHM1_1919,115,770 - 19,127,537 (-)NCBI
Sequence:
RefSeq Acc Id: NR_038064
RefSeq Status: REVIEWED
Type: NON-CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38919,115,761 - 19,127,492 (-)NCBI
GRCh37919,115,759 - 19,127,604 (-)ENTREZGENE
HuRef919,077,611 - 19,089,275 (-)ENTREZGENE
CHM1_1919,115,770 - 19,127,537 (-)NCBI
Sequence:
RefSeq Acc Id: XM_017014259   ⟹   XP_016869748
RefSeq Status:
Type: CODING
Position:
Human AssemblyChrPosition (strand)Source
GRCh38919,108,391 - 19,127,518 (-)NCBI
Sequence:
Reference Sequences
RefSeq Acc Id: NP_001113   ⟸   NM_001122
- UniProtKB: Q99541 (UniProtKB/Swiss-Prot),   Q6FHZ7 (UniProtKB/TrEMBL)
- Sequence:
RefSeq Acc Id: XP_016869748   ⟸   XM_017014259
- Peptide Label: isoform X1
- Sequence:
RefSeq Acc Id: ENSP00000369832   ⟸   ENST00000380465
RefSeq Acc Id: ENSP00000369831   ⟸   ENST00000380464
RefSeq Acc Id: ENSP00000276914   ⟸   ENST00000276914
RefSeq Acc Id: ENSP00000403421   ⟸   ENST00000434144

Promoters
RGD ID:6807552
Promoter ID:HG_KWN:62746
Type:CpG-Island
SO ACC ID:SO:0000170
Source:MPROMDB
Tissues & Cell Lines:CD4+TCell,   CD4+TCell_12Hour,   CD4+TCell_2Hour,   HeLa_S3,   K562,   Lymphoblastoid,   NB4
Transcripts:ENST00000380464,   OTTHUMT00000051829,   OTTHUMT00000051830,   OTTHUMT00000051835,   OTTHUMT00000051836
Position:
Human AssemblyChrPosition (strand)Source
Build 36919,117,431 - 19,118,312 (-)MPROMDB
RGD ID:6851712
Promoter ID:EP73658
Type:multiple initiation site
Name:HS_ADFP
Description:Adipose differentiation-related protein.
SO ACC ID:SO:0000170
Source:EPD (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:NEDO full length human cDNA sequencing project.; Oligo-capping
Position:
Human AssemblyChrPosition (strand)Source
Build 36919,117,490 - 19,117,550EPD
RGD ID:7214743
Promoter ID:EPDNEW_H13117
Type:initiation region
Name:PLIN2_1
Description:perilipin 2
SO ACC ID:SO:0000170
Source:EPDNEW (Eukaryotic Promoter Database, http://epd.vital-it.ch/)
Experiment Methods:Single-end sequencing.
Position:
Human AssemblyChrPosition (strand)Source
GRCh38919,127,492 - 19,127,552EPDNEW

Clinical Variants
Name Type Condition(s) Position(s) Clinical significance
GRCh38/hg38 9p24.3-13.1(chr9:204193-38815478)x3 copy number gain See cases [RCV000050357] Chr9:204193..38815478 [GRCh38]
Chr9:204193..38815475 [GRCh37]
Chr9:194193..38805475 [NCBI36]
Chr9:9p24.3-13.1
pathogenic|conflicting interpretations of pathogenicity|conflicting data from submitters
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain See cases [RCV000050348] Chr9:193412..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-13.1(chr9:204193-38741440)x3 copy number gain See cases [RCV000051106] Chr9:204193..38741440 [GRCh38]
Chr9:204193..38741437 [GRCh37]
Chr9:194193..38731437 [NCBI36]
Chr9:9p24.3-13.1
pathogenic
GRCh38/hg38 9p24.3-13.1(chr9:203993-38815619)x3 copy number gain See cases [RCV000053703] Chr9:203993..38815619 [GRCh38]
Chr9:203993..38815616 [GRCh37]
Chr9:193993..38805616 [NCBI36]
Chr9:9p24.3-13.1
pathogenic
GRCh38/hg38 9p24.3-21.3(chr9:204193-22086858)x3 copy number gain See cases [RCV000053704] Chr9:204193..22086858 [GRCh38]
Chr9:204193..22086857 [GRCh37]
Chr9:194193..22076857 [NCBI36]
Chr9:9p24.3-21.3
pathogenic
GRCh38/hg38 9p24.3-13.3(chr9:204193-34599437)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053706]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053706]|See cases [RCV000053706] Chr9:204193..34599437 [GRCh38]
Chr9:204193..34599435 [GRCh37]
Chr9:194193..34589435 [NCBI36]
Chr9:9p24.3-13.3
pathogenic
GRCh38/hg38 9p24.3-13.3(chr9:204193-33284638)x3 copy number gain See cases [RCV000053707] Chr9:204193..33284638 [GRCh38]
Chr9:204193..33284636 [GRCh37]
Chr9:194193..33274636 [NCBI36]
Chr9:9p24.3-13.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124532)x3 copy number gain See cases [RCV000053745] Chr9:193412..138124532 [GRCh38]
Chr9:204193..141018984 [GRCh37]
Chr9:194193..140138805 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-13.1(chr9:220253-38815419)x3 copy number gain See cases [RCV000053747] Chr9:220253..38815419 [GRCh38]
Chr9:220253..38815416 [GRCh37]
Chr9:210253..38805416 [NCBI36]
Chr9:9p24.3-13.1
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053748]|See cases [RCV000053748] Chr9:193412..138179445 [GRCh38]
Chr9:266045..141073897 [GRCh37]
Chr9:256045..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p23-21.1(chr9:9543538-30266463)x3 copy number gain See cases [RCV000053749] Chr9:9543538..30266463 [GRCh38]
Chr9:9543538..30266461 [GRCh37]
Chr9:9533538..30256461 [NCBI36]
Chr9:9p23-21.1
pathogenic
GRCh38/hg38 9p23-13.3(chr9:13526091-34261642)x3 copy number gain Developmental Delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053750]|Developmental delay and additional significant developmental and morphological phenotypes referred for genetic testing [RCV000053750]|See cases [RCV000053750] Chr9:13526091..34261642 [GRCh38]
Chr9:13526090..34261640 [GRCh37]
Chr9:13516090..34251640 [NCBI36]
Chr9:9p23-13.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138114463)x3 copy number gain See cases [RCV000053746] Chr9:193412..138114463 [GRCh38]
Chr9:214367..141008915 [GRCh37]
Chr9:204367..140128736 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:204193-138179445) copy number gain See cases [RCV000133791] Chr9:204193..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-21.1(chr9:220257-29424848)x3 copy number gain See cases [RCV000134037] Chr9:220257..29424848 [GRCh38]
Chr9:220257..29424846 [GRCh37]
Chr9:210257..29414846 [NCBI36]
Chr9:9p24.3-21.1
pathogenic
GRCh38/hg38 9p24.3-q21.11(chr9:13997-68401065)x3 copy number gain See cases [RCV000135344] Chr9:13997..68401065 [GRCh38]
Chr9:13997..71015981 [GRCh37]
Chr9:3997..70205801 [NCBI36]
Chr9:9p24.3-q21.11
pathogenic
GRCh38/hg38 9p24.3-q21.12(chr9:193412-70630731)x3 copy number gain See cases [RCV000136152] Chr9:193412..70630731 [GRCh38]
Chr9:220253..73245647 [GRCh37]
Chr9:210253..72435467 [NCBI36]
Chr9:9p24.3-q21.12
pathogenic
GRCh38/hg38 9p24.3-q21.13(chr9:193412-74615913)x3 copy number gain See cases [RCV000135954] Chr9:193412..74615913 [GRCh38]
Chr9:204193..77230829 [GRCh37]
Chr9:194193..76420649 [NCBI36]
Chr9:9p24.3-q21.13
pathogenic
GRCh38/hg38 9p24.1-21.2(chr9:4661872-27661572)x3 copy number gain See cases [RCV000136680] Chr9:4661872..27661572 [GRCh38]
Chr9:4661872..27661570 [GRCh37]
Chr9:4651872..27651570 [NCBI36]
Chr9:9p24.1-21.2
pathogenic
GRCh38/hg38 9p24.1-13.2(chr9:7162304-37038771)x3 copy number gain See cases [RCV000137741] Chr9:7162304..37038771 [GRCh38]
Chr9:7162304..37038768 [GRCh37]
Chr9:7152304..37028768 [NCBI36]
Chr9:9p24.1-13.2
pathogenic
GRCh38/hg38 9p24.3-q21.11(chr9:204104-66233120)x4 copy number gain See cases [RCV000137888] Chr9:204104..66233120 [GRCh38]
Chr9:204104..47212321 [GRCh37]
Chr9:194104..47002141 [NCBI36]
Chr9:9p24.3-q21.11
pathogenic|conflicting data from submitters
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138124524)x3 copy number gain See cases [RCV000138783] Chr9:193412..138124524 [GRCh38]
Chr9:204090..141018976 [GRCh37]
Chr9:194090..140138797 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-21.3(chr9:459131-24207894)x3 copy number gain See cases [RCV000138499] Chr9:459131..24207894 [GRCh38]
Chr9:459131..24207892 [GRCh37]
Chr9:449131..24197892 [NCBI36]
Chr9:9p24.3-21.3
pathogenic
GRCh38/hg38 9p24.3-q21.11(chr9:204104-67549861)x3 copy number gain See cases [RCV000139208] Chr9:204104..67549861 [GRCh38]
Chr9:204104..66516698 [GRCh37]
Chr9:194104..66256518 [NCBI36]
Chr9:9p24.3-q21.11
pathogenic
GRCh38/hg38 9p24.3-13.3(chr9:204104-34151476)x3 copy number gain See cases [RCV000139015] Chr9:204104..34151476 [GRCh38]
Chr9:204104..34151474 [GRCh37]
Chr9:194104..34141474 [NCBI36]
Chr9:9p24.3-13.3
pathogenic|likely benign
GRCh38/hg38 9p24.3-13.1(chr9:204104-38768294)x3 copy number gain See cases [RCV000139126] Chr9:204104..38768294 [GRCh38]
Chr9:204104..38768291 [GRCh37]
Chr9:194104..38758291 [NCBI36]
Chr9:9p24.3-13.1
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138159073)x3 copy number gain See cases [RCV000138962] Chr9:193412..138159073 [GRCh38]
Chr9:204104..141053525 [GRCh37]
Chr9:194104..140173346 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic|conflicting data from submitters
GRCh38/hg38 9p22.2-q21.11(chr9:18344605-68257015) copy number gain See cases [RCV000140448] Chr9:18344605..68257015 [GRCh38]
Chr9:18344603..68995221 [GRCh37]
Chr9:18334603..68285041 [NCBI36]
Chr9:9p22.2-q21.11
pathogenic
GRCh38/hg38 9p24.3-21.2(chr9:204104-27963369)x3 copy number gain See cases [RCV000139621] Chr9:204104..27963369 [GRCh38]
Chr9:204104..27963367 [GRCh37]
Chr9:194104..27953367 [NCBI36]
Chr9:9p24.3-21.2
pathogenic
GRCh38/hg38 9p24.3-q22.1(chr9:203861-88130444)x4 copy number gain See cases [RCV000141904] Chr9:203861..88130444 [GRCh38]
Chr9:203861..90745359 [GRCh37]
Chr9:193861..89935179 [NCBI36]
Chr9:9p24.3-q22.1
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:203861-138125937)x3 copy number gain See cases [RCV000141876] Chr9:203861..138125937 [GRCh38]
Chr9:203861..141020389 [GRCh37]
Chr9:193861..140140210 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-21.1(chr9:203861-31423873)x4 copy number gain See cases [RCV000141662] Chr9:203861..31423873 [GRCh38]
Chr9:203861..31423871 [GRCh37]
Chr9:193861..31413871 [NCBI36]
Chr9:9p24.3-21.1
pathogenic
GRCh38/hg38 9p24.3-q21.31(chr9:193412-79877816)x3 copy number gain See cases [RCV000143012] Chr9:193412..79877816 [GRCh38]
Chr9:204104..82492731 [GRCh37]
Chr9:194104..81682551 [NCBI36]
Chr9:9p24.3-q21.31
pathogenic
GRCh38/hg38 9p24.3-13.1(chr9:203861-38381642) copy number gain See cases [RCV000143411] Chr9:203861..38381642 [GRCh38]
Chr9:203861..38381639 [GRCh37]
Chr9:193861..38371639 [NCBI36]
Chr9:9p24.3-13.1
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:203862-138125937)x3 copy number gain See cases [RCV000143476] Chr9:203862..138125937 [GRCh38]
Chr9:203862..141020389 [GRCh37]
Chr9:193862..140140210 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-q34.3(chr9:193412-138179445)x3 copy number gain See cases [RCV000148113] Chr9:193412..138179445 [GRCh38]
Chr9:204193..141073897 [GRCh37]
Chr9:194193..140193718 [NCBI36]
Chr9:9p24.3-q34.3
pathogenic
GRCh38/hg38 9p24.3-13.1(chr9:204193-38815478)x3 copy number gain See cases [RCV000148159] Chr9:204193..38815478 [GRCh38]
Chr9:204193..38815475 [GRCh37]
Chr9:194193..38805475 [NCBI36]
Chr9:9p24.3-13.1
pathogenic
GRCh38/hg38 9p11.2-q34.3(chr9:193412-138159073)x3 copy number gain See cases [RCV000139207] Chr9:193412..138159073 [GRCh38]
Chr9:68420641..141053525 [GRCh37]
Chr9:67910461..140173346 [NCBI36]
Chr9:9p11.2-q34.3
pathogenic
GRCh37/hg19 9p24.3-13.1(chr9:163131-38763958)x3 copy number gain See cases [RCV000240201] Chr9:163131..38763958 [GRCh37]
Chr9:9p24.3-13.1
pathogenic
GRCh37/hg19 9p24.3-11.2(chr9:213161-47212321)x4 copy number gain See cases [RCV000240048] Chr9:213161..47212321 [GRCh37]
Chr9:9p24.3-11.2
pathogenic
GRCh37/hg19 9p24.3-13.1(chr9:213161-39092820)x3 copy number gain See cases [RCV000239869] Chr9:213161..39092820 [GRCh37]
Chr9:9p24.3-13.1
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:163131-141122114)x3 copy number gain See cases [RCV000240081] Chr9:163131..141122114 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-22.1(chr9:213161-19450250)x3 copy number gain See cases [RCV000240225] Chr9:213161..19450250 [GRCh37]
Chr9:9p24.3-22.1
pathogenic
GRCh37/hg19 9p24.3-q13(chr9:203861-68188391)x4 copy number gain See cases [RCV000449165] Chr9:203861..68188391 [GRCh37]
Chr9:9p24.3-q13
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:62525-141006407) copy number gain See cases [RCV000449375] Chr9:62525..141006407 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020389)x3 copy number gain See cases [RCV000447207] Chr9:203861..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-13.1(chr9:32396-39140211) copy number gain See cases [RCV000447246] Chr9:32396..39140211 [GRCh37]
Chr9:9p24.3-13.1
pathogenic
GRCh37/hg19 9p24.3-q13(chr9:203861-67983174)x4 copy number gain See cases [RCV000446521] Chr9:203861..67983174 [GRCh37]
Chr9:9p24.3-q13
pathogenic
GRCh37/hg19 9p24.3-q21.11(chr9:13997-70919878)x4 copy number gain See cases [RCV000448242] Chr9:13997..70919878 [GRCh37]
Chr9:9p24.3-q21.11
pathogenic
GRCh37/hg19 9p24.3-q21.11(chr9:203861-69002883)x3 copy number gain See cases [RCV000448569] Chr9:203861..69002883 [GRCh37]
Chr9:9p24.3-q21.11
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203864-141020389)x3 copy number gain See cases [RCV000448978] Chr9:203864..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p22.2-21.1(chr9:17684434-30889762)x3 copy number gain See cases [RCV000510665] Chr9:17684434..30889762 [GRCh37]
Chr9:9p22.2-21.1
pathogenic
GRCh37/hg19 9p24.1-21.1(chr9:5900425-30008330)x3 copy number gain See cases [RCV000510425] Chr9:5900425..30008330 [GRCh37]
Chr9:9p24.1-21.1
pathogenic
GRCh37/hg19 9p22.1(chr9:18580904-19377336)x4 copy number gain See cases [RCV000511542] Chr9:18580904..19377336 [GRCh37]
Chr9:9p22.1
likely benign
GRCh37/hg19 9p24.3-13.1(chr9:203861-38787480)x3 copy number gain See cases [RCV000510864] Chr9:203861..38787480 [GRCh37]
Chr9:9p24.3-13.1
pathogenic
GRCh37/hg19 9p22.2-13.3(chr9:17132123-35567051)x3 copy number gain See cases [RCV000510986] Chr9:17132123..35567051 [GRCh37]
Chr9:9p22.2-13.3
pathogenic
GRCh37/hg19 9p23-21.2(chr9:10320113-26205565)x1 copy number loss PARP Inhibitor response [RCV000626433] Chr9:10320113..26205565 [GRCh37]
Chr9:9p23-21.2
drug response
GRCh37/hg19 9p24.3-11.2(chr9:204193-44259464)x4 copy number gain Syndromic hydrocephalus due to diffuse villous hyperplasia of choroid plexus [RCV000677299] Chr9:204193..44259464 [GRCh37]
Chr9:9p24.3-11.2
likely pathogenic
GRCh37/hg19 9p24.3-q21.33(chr9:203861-88189913)x3 copy number gain See cases [RCV000512431] Chr9:203861..88189913 [GRCh37]
Chr9:9p24.3-q21.33
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203862-141020389) copy number gain See cases [RCV000512392] Chr9:203862..141020389 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-21.3(chr9:203861-20653468)x3 copy number gain not provided [RCV000683170] Chr9:203861..20653468 [GRCh37]
Chr9:9p24.3-21.3
pathogenic
GRCh37/hg19 9p22.1(chr9:18935985-19603778)x3 copy number gain not provided [RCV000683139] Chr9:18935985..19603778 [GRCh37]
Chr9:9p22.1
uncertain significance
GRCh37/hg19 9p22.1-21.3(chr9:18944282-19964747)x3 copy number gain not provided [RCV000683150] Chr9:18944282..19964747 [GRCh37]
Chr9:9p22.1-21.3
uncertain significance
GRCh37/hg19 9p24.3-13.1(chr9:203861-38787480)x3 copy number gain not provided [RCV000683172] Chr9:203861..38787480 [GRCh37]
Chr9:9p24.3-13.1
pathogenic
GRCh37/hg19 9p24.3-q13(chr9:203861-67983174)x4 copy number gain not provided [RCV000683173] Chr9:203861..67983174 [GRCh37]
Chr9:9p24.3-q13
pathogenic
GRCh37/hg19 9p24.3-21.2(chr9:203861-26397133)x3 copy number gain not provided [RCV000683171] Chr9:203861..26397133 [GRCh37]
Chr9:9p24.3-21.2
pathogenic
GRCh37/hg19 9p24.3-q13(chr9:203861-68262804)x3,4 copy number gain not provided [RCV000683174] Chr9:203861..68262804 [GRCh37]
Chr9:9p24.3-q13
pathogenic
GRCh37/hg19 9p24.3-q21.12(chr9:203861-72717793)x3 copy number gain not provided [RCV000683176] Chr9:203861..72717793 [GRCh37]
Chr9:9p24.3-q21.12
pathogenic
GRCh37/hg19 9p24.3-q21.11(chr9:203861-70985795)x4 copy number gain not provided [RCV000683175] Chr9:203861..70985795 [GRCh37]
Chr9:9p24.3-q21.11
pathogenic
GRCh37/hg19 9p22.1(chr9:19102828-19127877)x1 copy number loss not provided [RCV000748272] Chr9:19102828..19127877 [GRCh37]
Chr9:9p22.1
benign
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141122247)x3 copy number gain not provided [RCV000748055] Chr9:10590..141122247 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-21.3(chr9:46587-22012051)x3 copy number gain not provided [RCV000748062] Chr9:46587..22012051 [GRCh37]
Chr9:9p24.3-21.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141107672)x3 copy number gain not provided [RCV000748053] Chr9:10590..141107672 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:46587-141066491)x3 copy number gain not provided [RCV000748063] Chr9:46587..141066491 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:10590-141114095)x2 copy number gain not provided [RCV000748054] Chr9:10590..141114095 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.2-21.3(chr9:4420767-22195820)x3 copy number gain not provided [RCV000748122] Chr9:4420767..22195820 [GRCh37]
Chr9:9p24.2-21.3
pathogenic
NM_001122.4(PLIN2):c.493G>C (p.Gly165Arg) single nucleotide variant not provided [RCV000897363] Chr9:19120982 [GRCh38]
Chr9:19120980 [GRCh37]
Chr9:9p22.1
benign
GRCh37/hg19 9p24.3-13.1(chr9:203861-38472979)x3 copy number gain not provided [RCV000848175] Chr9:203861..38472979 [GRCh37]
Chr9:9p24.3-13.1
pathogenic
GRCh37/hg19 9p24.3-q34.3(chr9:203861-141020388)x3 copy number gain not provided [RCV000845900] Chr9:203861..141020388 [GRCh37]
Chr9:9p24.3-q34.3
pathogenic
GRCh37/hg19 9p24.3-13.1(chr9:214309-39156958) copy number gain not provided [RCV000767644] Chr9:214309..39156958 [GRCh37]
Chr9:9p24.3-13.1
pathogenic
GRCh37/hg19 9p24.3-22.1(chr9:203861-19448473)x3 copy number gain not provided [RCV000845664] Chr9:203861..19448473 [GRCh37]
Chr9:9p24.3-22.1
pathogenic
GRCh37/hg19 9p22.2-22.1(chr9:18214877-19289427)x3 copy number gain not provided [RCV000847984] Chr9:18214877..19289427 [GRCh37]
Chr9:9p22.2-22.1
uncertain significance
GRCh37/hg19 9p22.1(chr9:19080351-19544088)x3 copy number gain not provided [RCV001006219] Chr9:19080351..19544088 [GRCh37]
Chr9:9p22.1
uncertain significance
GRCh37/hg19 9p24.3-q13(chr9:203861-67986965)x3 copy number gain not provided [RCV000845815] Chr9:203861..67986965 [GRCh37]
Chr9:9p24.3-q13
pathogenic
NM_001122.4(PLIN2):c.971C>T (p.Thr324Met) single nucleotide variant not provided [RCV000964305] Chr9:19116591 [GRCh38]
Chr9:19116589 [GRCh37]
Chr9:9p22.1
benign
GRCh37/hg19 9p24.3-q21.11(chr9:203861-70984588)x3 copy number gain not provided [RCV001006167] Chr9:203861..70984588 [GRCh37]
Chr9:9p24.3-q21.11
pathogenic
GRCh37/hg19 9p22.1(chr9:19108473-19329836)x1 copy number loss not provided [RCV001260066] Chr9:19108473..19329836 [GRCh37]
Chr9:9p22.1
uncertain significance

Additional Information

Database Acc Id Source(s)
AGR Gene HGNC:248 AgrOrtholog
COSMIC PLIN2 COSMIC
Ensembl Genes ENSG00000147872 Ensembl, ENTREZGENE, UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
Ensembl Protein ENSP00000276914 ENTREZGENE, UniProtKB/Swiss-Prot
  ENSP00000369831 UniProtKB/TrEMBL
  ENSP00000369832 UniProtKB/TrEMBL
  ENSP00000403421 UniProtKB/TrEMBL
Ensembl Transcript ENST00000276914 ENTREZGENE, UniProtKB/Swiss-Prot
  ENST00000380464 UniProtKB/TrEMBL
  ENST00000380465 UniProtKB/TrEMBL
  ENST00000434144 UniProtKB/TrEMBL
GTEx ENSG00000147872 GTEx
HGNC ID HGNC:248 ENTREZGENE
Human Proteome Map PLIN2 Human Proteome Map
InterPro Perilipin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
KEGG Report hsa:123 UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
NCBI Gene 123 ENTREZGENE
OMIM 103195 OMIM
Pfam Perilipin UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
PharmGKB PA24569 PharmGKB
PIRSF PAT UniProtKB/Swiss-Prot, UniProtKB/TrEMBL
UniProt PLIN2_HUMAN UniProtKB/Swiss-Prot
  Q5SYF3_HUMAN UniProtKB/TrEMBL
  Q5SYF4_HUMAN UniProtKB/TrEMBL
  Q5SYF5_HUMAN UniProtKB/TrEMBL
  Q6FHZ7 ENTREZGENE, UniProtKB/TrEMBL
  Q99541 ENTREZGENE
UniProt Secondary Q9BSC3 UniProtKB/Swiss-Prot


Nomenclature History
Date Current Symbol Current Name Previous Symbol Previous Name Description Reference Status
2011-08-16 PLIN2  perilipin 2  PLIN2  perilipin 2  Symbol and/or name change 5135510 APPROVED
2011-07-27 PLIN2  perilipin 2  ADFP  adipose differentiation-related protein  Symbol and/or name change 5135510 APPROVED